The results illustrated IGF2BP3 can be used to well distinguish severe OSA patients from normal healthy (AUC = 0.825) (Figure 3E) and also reached a higher level in the validation set (AUC = 0.766) (Figure 3F), indicating that IGF2BP3 had a high diagnostic value. Here, IGF2BP3 is linked to obstructive sleep apnea syndrome.